{"id":"e12b14fad259","type":"article","url":"https://hartvaat.nl/2023/04/21/cardiometabole-gezondheid-bij-kinderen-geboren-na-ivf/","title":"Cardiometabole gezondheid bij kinderen geboren na IVF","title_en":"Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysis.","category":"hypertensie","category_label":"Hypertensie","professions":["huisarts","internist"],"tags":["diabetes-en-hart","farmaco-economie","gepersonaliseerde-geneeskunde","hartrevalidatie","menopauze","obesitas","ouderen","vrouwen"],"journal":"European heart journal","doi":"10.1093/eurheartj/ehac726","source_url":"https://doi.org/10.1093/eurheartj/ehac726","authors":["Ahmed Elhakeem","Amy E Taylor","Hazel M Inskip","Jonathan Y Huang","Toby Mansell","Carina Rodrigues","Federica Asta","Sophia M Blaauwendraad","Siri E Håberg","Jane Halliday","Margreet W Harskamp-van Ginkel","Jian-Rong He","Vincent W V Jaddoe","Sharon Lewis","Gillian M Maher","Yannis Manios","Fergus P McCarthy","Irwin K M Reiss","Franca Rusconi","Theodosia Salika","Muriel Tafflet","Xiu Qiu","Bjørn O Åsvold","David Burgner","Jerry K Y Chan","Luigi Gagliardi","Romy Gaillard","Barbara Heude","Maria C Magnus","George Moschonis","Deirdre Murray","Scott M Nelson","Daniela Porta","Richard Saffery","Henrique Barros","Johan G Eriksson","Tanja G M Vrijkotte","Deborah A Lawlor"],"significance":5,"published":"2023-04-21","source_date":"2023-04-21","image":"","kennis":[],"congress":"","summary_en":"This multi-cohort analysis showed that children born after assisted reproductive technology have a slightly less favorable cardiometabolic profile compared with naturally conceived children, warranting long-term cardiovascular follow-up.","created":"2026-07-03T10:30:20Z","updated":"2026-07-03T13:29:25Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Multi-cohort analyse toonde dat kinderen geboren na geassisteerde reproductietechnologie een iets ongunstiger cardiometabool profiel hebben dan natuurlijk verwekte kinderen. De verschillen zijn klein maar verdienen langetermijnmonitoring.","abstract_original":"AIMS: To examine associations of assisted reproductive technology (ART) conception (vs. natural conception: NC) with offspring cardiometabolic health outcomes and whether these differ with age. METHODS AND RESULTS: Differences in systolic (SBP) and diastolic blood pressure (DBP), heart rate (HR), lipids, and hyperglycaemic/insulin resistance markers were examined using multiple linear regression models in 14 population-based birth cohorts in Europe, Australia, and Singapore, and results were combined using meta-analysis. Change in cardiometabolic outcomes from 2 to 26 years was examined using trajectory modelling of four cohorts with repeated measures. 35 938 (654 ART) offspring were included in the meta-analysis. Mean age ranged from 13 months to 27.4 years but was <10 years in 11/14 cohorts. Meta-analysis found no statistical difference (ART minus NC) in SBP (-0.53 mmHg; 95% CI:-1.59 to 0.53), DBP (-0.24 mmHg; -0.83 to 0.35), or HR (0.02 beat/min; -0.91 to 0.94). Total cholesterol (2.59%; 0.10-5.07), HDL cholesterol (4.16%; 2.52-5.81), LDL cholesterol (4.95%; 0.47-9.43) were statistically significantly higher in ART-conceived vs. NC offspring. No statistical difference was seen for triglycerides (TG), glucose, insulin, and glycated haemoglobin. Long-term follow-up of 17 244 (244 ART) births identified statistically significant associations between ART and lower predicted SBP/DBP in childhood, and subtle trajectories to higher SBP and TG in young adulthood; however, most differences were not statistically significant. CONCLUSION: These findings of small and statistically non-significant differences in offspring cardiometabolic outcomes should reassure people receiving ART. Longer-term follow-up is warranted to investigate changes over adulthood in the risks of hypertension, dyslipidaemia, and preclinical and clinical cardiovascular disease."}